賽諾醫療(688108.SH):冠脈產品在海外獲得註冊證
格隆匯2月13日丨賽諾醫療(688108.SH)公佈,公司於2024年9月向阿根廷共和國國家藥品、食品和醫療技術管理局 Administración Nacional deMedicamentos,
Alimentos y Tecnología Médica,(以下簡稱“ANMAT”)遞交了公司HT Supreme™藥物洗脫支架系統的註冊申報資料。於2024年10月向厄瓜多爾共和國國家衛生監管控制與監督局 Agencia Nacional de Regulación, Control y
VigilanciaSanitaria,(以下簡稱“ARCSA”)遞交了公司 HT Supreme™藥物洗脫支架系統、TytrakPTCA 球囊擴張導管以及
NC Thonic 非順應性 PTCA 球囊擴張導管的註冊申報資料。公司於近日收到 ANMAT 和 ARCSA 通知,遞交的註冊申報資料獲得 ANMAT 和
ARCSA
的批準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.